Let’s build chronic disease follow-up in West Africa together.
Blâdemy moves forward with public health bodies, caregivers and funders. Hospitals, research institutes, investors: join them.
Institutional backing, field partners, and awards that validate the project.
Institutional backing
-
PNLMM / PMNT National programme against metabolic diseases and for the prevention of non-communicable diseases: a signed institutional partnership. -
DISD Direction de l’Informatique et de la Santé Digitale (IT and digital health directorate).
Field and expertise
-
ADN Pharma Digital health and medical equipment: carries Blâdemy’s infrastructure in Côte d’Ivoire. -
SunWaves MedTech Medtech based in Nice, France: scientific expertise and medical-watch methodology for the pilot programme. -
Terminus 2π ↗ Data and AI technology strategy, Europe and Africa. -
Hôpital à domicile Care and follow-up of patients at home.
Funding and support
-
FasterCapital · EquityPilot Funding and fundraising support -
Finnovatix ↗ Exclusive partnership: public funding and fundraising, in France and Africa. -
DSC Finance Financial partner.
Awards
- MTN Y’ello Startup 2022 winner: validation by a leading telecom operator.
- ODESS · Fondation Pierre Fabre Eligible for the 2027 final phase of the Observatory of e-health in the countries of the South.
- PAES · CDC-CI Capital × Plug and Play Selected in the Top 20 of the 2026 edition of this demanding acceleration programme.
-
Pr Alexandre Mebazaa Scientific patron -
Dr Kouakou K. Ernest Principal investigator
Your place in the project.
We are looking for new partners for the 2027 pilot test, real-world data collection and the roll-out across West Africa.
- Hospitals and healthcare facilities
Follow your patients between two visits.
Bring Blâdemy into your department: diabetic and hypertensive patients equipped with a kit, caregivers alerted in time on a dashboard, a facility involved in the pilot test and then the roll-out.
- Research institutes and health programmes
Advance research on chronic diseases.
Build protocols together, rely on sovereign real-world data, collected with patients’ consent and anonymised, and measure the effect of home follow-up on a population still little studied.
- Investors and financial partners
Fund clinical validation and the roll-out.
Back Blâdemy from the 2027 pilot test to international expansion from 2029, with technology that works where others stop. The investor deck is sent on request.
See the investor space →
A manufacturer, telecom operator, insurer or NGO? Write to us too. Write to us →
Does your facility, institute or fund want to join Blâdemy?
Tell us who you are and what you have in mind: we will get back to you to talk it through.